A study on chronologic change of the relationship between cigarette smoking and lung cancer based on autopsy diagnosis.

Abstract:

:Human cases autopsied at the Department of Pathology, University of Tokyo, were studied to investigate the chronologic changes in the relationship between cigarette smoking and lung cancer occurrence. The results obtained were as follows: (1) it was confirmed that the incidence of lung cancer was significantly higher among cigarette smokers than among nonsmokers, and that there was a definite dose-response relationship between the quantity of cigarettes smoked and the occurrence of lung cancer; and (2) over the time span studied, the incidence of lung cancer among autopsies showed a remarkable increase. However, this tendency was seen in both cigarette smokers and nonsmokers, and in fact, the increase was comparatively higher in the latter group. It should be stressed that the relative importance of cigarette smoking in human pulmonary carcinogenesis seems to have decreased in the past 40 years or so, and factors other than cigarette smoking seems to have become more important.

journal_name

Cancer

journal_title

Cancer

authors

Mori W,Sakai R

doi

10.1002/1097-0142(19840915)54:6<1038::aid-cncr2820

subject

Has Abstract

pub_date

1984-09-15 00:00:00

pages

1038-42

issue

6

eissn

0008-543X

issn

1097-0142

journal_volume

54

pub_type

杂志文章

相关文献

CANCER文献大全
  • Gemcitabine and platinum combinations in pancreatic cancer.

    abstract::Progress in the treatment of pancreatic cancer in the past several decades has been very modest. Several new agents with activity against this disease have been identified. Of these, gemcitabine appears to be the most promising when used in combination with other drugs. Gemcitabine and cisplatin combinations have been...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.10757

    authors: Philip PA

    更新日期:2002-08-15 00:00:00

  • Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinoma: a multicenter study.

    abstract:BACKGROUND:The malignant biological behavior of small-sized lung adenocarcinomas remains obscure, although understanding this feature is important for selecting appropriate treatment. In the current study, the authors evaluated malignancy grades of small adenocarcinomas using fluorodeoxyglucose-positron emission tomogr...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/cncr.25244

    authors: Nakayama H,Okumura S,Daisaki H,Kato Y,Uehara H,Adachi S,Yoshimura M,Okada M

    更新日期:2010-07-01 00:00:00

  • Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer.

    abstract:BACKGROUND:MicroRNAs (miRNAs) play a crucial role in carcinogenesis; however, it largely remains unclear whether miRNAs in gastric juice, which is specific for gastric tissues, can be used as biomarkers for gastric cancer. The objective of the current study was to investigate the feasibility of using gastric juice miRN...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27903

    authors: Cui L,Zhang X,Ye G,Zheng T,Song H,Deng H,Xiao B,Xia T,Yu X,Le Y,Guo J

    更新日期:2013-05-01 00:00:00

  • Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas.

    abstract:BACKGROUND:Patients with advanced soft tissue sarcomas (STS) have limited therapeutic options. Sorafenib (BAY 43-9006) is a multitargeted tyrosine kinase inhibitor of raf, vascular endothelial growth factor receptors 1 (VEGFR1) through 3, platelet-derived growth factor B, fms-like tyrosine kinase 3, and c-kit, and some...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.26334

    authors: von Mehren M,Rankin C,Goldblum JR,Demetri GD,Bramwell V,Ryan CW,Borden E

    更新日期:2012-02-01 00:00:00

  • Parosteal osteogenic sarcoma.

    abstract::A clinicopathologic study of 79 patients with parosteal osteogenic sarcoma revealed that more females than males were affected and that most of the patients were in the second to the fourth decades of life. Sixty-eight percent of the patients had involvement of the posterior aspect of the lower femoral shaft. The roen...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197605)37:5<2466::aid-cncr282037

    authors: Unni KK,Dahlin DC,Beabout JW,Ivins JC

    更新日期:1976-05-01 00:00:00

  • Chemoprevention: drug pricing and mortality: the case of tamoxifen.

    abstract:BACKGROUND:Tamoxifen is a prototypic cancer chemopreventive agent, yet clinical trials have not evaluated its effect on mortality or the impact of drug pricing on its cost-effectiveness. METHODS:A state-transition Markov model for a hypothetical cohort of women age 50 years was used to evaluate the effects of tamoxife...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22075

    authors: Melnikow J,Kuenneth C,Helms LJ,Barnato A,Kuppermann M,Birch S,Nuovo J

    更新日期:2006-09-01 00:00:00

  • The prognostic significance of nuclear DNA content in prostatic carcinoma.

    abstract::The prognostic significance of ploidy level was studied in prostatic carcinoma and compared with the prognostic significance of morphologic grade and clinical stage. A nonselected group of 145 patients was studied in whom prostatic carcinoma was diagnosed by fine-needle aspiration biopsy at the Karolinska Hospital in ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920315)69:6<1432::aid-cncr2820

    authors: Forsslund G,Esposti PL,Nilsson B,Zetterberg A

    更新日期:1992-03-15 00:00:00

  • Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.

    abstract::Between March 1973, and December 1976, 22 patients who developed disease progression during or after MOPP therapy were treated with a new combination, B-CAVe (Bleomycin 5 mg/m2 iv days 1, 28, 35; CCNU 100 mg/m2 po day 1; adriamycin 60 mg/m2 iv day 1; and vinblastine 5 mg/m2 iv day 1). Objective responses were achieved...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197805)41:5<1670::aid-cncr282041

    authors: Porzig KJ,Portlock CS,Robertson A,Rosenberg SA

    更新日期:1978-05-01 00:00:00

  • Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma.

    abstract:BACKGROUND:Treatment of localized prostate carcinoma (LPC) using radiotherapy (RT) can induce disturbances in a patient's quality of life (QOL) and urinary and intestinal function. Late symptoms and QOL were evaluated in a randomized trial between RT and deferred treatment (DT). METHODS:Quality of life was evaluated w...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(20011215)92:12<3111::aid-cncr101

    authors: Fransson P,Damber JE,Tomic R,Modig H,Nyberg G,Widmark A

    更新日期:2001-12-15 00:00:00

  • Analysis of prognostic factors in patients with isolated chest wall recurrence of breast cancer.

    abstract::A retrospective analysis of a series of 162 patients treated for isolated chest wall recurrence of breast cancer after mastectomy was undertaken. Cumulative survival, distant relapse-free survival, and freedom from local progression after 5 years from the diagnosis of recurrence were 34%, 28%, and 45% respectively. Fi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870715)60:2<240::aid-cncr28206

    authors: Magno L,Bignardi M,Micheletti E,Bardelli D,Plebani F

    更新日期:1987-07-15 00:00:00

  • Delays in diagnosis and bladder cancer mortality.

    abstract:BACKGROUND:Mortality from invasive bladder cancer is common, even with high-quality care. Thus, the best opportunities to improve outcomes may precede the diagnosis. Although screening currently is not recommended, better medical care of patients who are at risk (ie, those with hematuria) has the potential to improve o...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25310

    authors: Hollenbeck BK,Dunn RL,Ye Z,Hollingsworth JM,Skolarus TA,Kim SP,Montie JE,Lee CT,Wood DP Jr,Miller DC

    更新日期:2010-11-15 00:00:00

  • Laparoscopy and biopsy in malignant liver disease.

    abstract::Laparoscopy is highly effective in diagnosing malignant liver disease, with overall accuracy in the 90% range. Up to 80% of the liver surface can be inspected, and biopsies can be directed with precision. A major advantage over scan guided percutaneous techniques is the ability to detect and biopsy lesions only a few ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Lightdale CJ

    更新日期:1982-12-01 00:00:00

  • Testis cancer. Ichthyosis constitutes a significant risk factor.

    abstract::Testis cancer and ichthyosis are both relatively rare diseases. Hence the finding of six individuals with both these conditions in a small population with testicular cancer is highly conspicuous and indicates some kind of connection among such persons. Despite the identical clinical appearances of their ichthyoses, th...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910201)67:3<730::aid-cncr28206

    authors: Lykkesfeldt G,Bennett P,Lykkesfeldt AE,Micic S,Rørth M,Skakkebaek NE,Svenstrup B

    更新日期:1991-02-01 00:00:00

  • A prospective evaluation of the effect of tumor cell DNA content on recurrence in colorectal cancer.

    abstract::Tumor cell DNA (ploidy) content was measured prospectively in samples from 320 patients resected for colorectal cancer with a minimum follow-up time of 2 years. All patients were followed and those with recurrence were investigated carefully. There was no correlation between tumors with an abnormal cellular DNA conten...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910515)67:10<2599::aid-cncr282

    authors: Armitage NC,Ballantyne KC,Sheffield JP,Clarke P,Evans DF,Hardcastle JD

    更新日期:1991-05-15 00:00:00

  • Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment.

    abstract:BACKGROUND:Many patients with stage III colon adenocarcinoma do not receive adjuvant chemotherapy despite the proven survival advantage it offers. To enhance the provision of optimal cancer care, patient characteristics associated with not receiving guideline-adherent treatment must be identified among patients with op...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25250

    authors: Winget M,Hossain S,Yasui Y,Scarfe A

    更新日期:2010-10-15 00:00:00

  • Comparison of long-term survival of 1986 consecutive patients with breast cancer treated at the National Cancer Institute of Milano, Italy (1971 to 1972 and 1977 to 1978).

    abstract::Long-term survival of 1986 consecutive patients with infiltrating duct carcinoma of the breast treated at the National Cancer Institute of Milano (Italy) in two periods of time (1971 to 1972 and 1977 to 1978) was comparatively evaluated to verify if the evolving concepts in the management of breast cancer had an impac...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910715)68:2<427::aid-cncr28206

    authors: Cascinelli N,Greco M,Morabito A,Bufalino R,Testori A,Baldini MT,Andreola S,Leo E,Galluzzo D,Rilke F

    更新日期:1991-07-15 00:00:00

  • Preoperative irradiation in carcinoma of the pancreas.

    abstract::Seventeen patients with carcinoma confined to the pancreas and the peripancreatic area received preoperative radiation therapy in an attempt to increase the resectability rate and to reduce the incidence of recurrence. The tumors were considered either unresectable or of borderline resectability. The radiation dose ra...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19801101)46:9<1945::aid-cncr2820

    authors: Pilepich MV,Miller HH

    更新日期:1980-11-01 00:00:00

  • Comparative genomic hybridization analysis of genetic aberrations associated with development and progression of biliary tract carcinomas.

    abstract:BACKGROUND:Little is known about genetic aberrations associated with development and progression of biliary tract carcinomas. METHODS:To study chromosomal aberrations associated with development and progression of biliary tract carcinomas, the authors used comparative genomic hybridization to examine 50 such carcinoma...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010201)91:3<570::aid-cncr1036>

    authors: Shiraishi K,Okita K,Harada T,Kusano N,Furui T,Kondoh S,Oga A,Kawauchi S,Fukumoto Y,Sasaki K

    更新日期:2001-02-01 00:00:00

  • Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome.

    abstract:BACKGROUND:The presence of single-nucleotide polymorphisms (SNPs) within the 3'-untranslated regions of genes could affect the binding between a microRNA (miRNA) and its target, with consequences on gene expression regulation. Considering the important role of miRNAs in carcinogenesis, it is hypothesized here that thes...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27435

    authors: Landi D,Gemignani F,Pardini B,Naccarati A,Garritano S,Vodicka P,Vodickova L,Canzian F,Novotny J,Barale R,Landi S

    更新日期:2012-10-01 00:00:00

  • Prognostic value of the plasminogen activation system in patients with gastric carcinoma.

    abstract:BACKGROUND:Patients with gastric cancer have a poor prognosis and can be cured by surgery only if the cancer is detected in an early stage. Extended surgery, down staging with chemotherapy before operation, and new postoperative treatments are recent approaches to increase survival rates. Categorizing patients' prognos...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19960315)77:6<1035::aid-cn

    authors: Ganesh S,Sier CF,Heerding MM,van Krieken JH,Griffioen G,Welvaart K,van de Velde CJ,Verheijen JH,Lamers CB,Verspaget HW

    更新日期:1996-03-15 00:00:00

  • Humoral hypercalcemia in patients with colorectal carcinoma: report of two cases and review of the literature.

    abstract:BACKGROUND:Humoral hypercalcemia rarely is associated with colorectal carcinoma; to the authors' knowledge only nine cases have been reported to date. METHODS:Two cases of advanced colorectal carcinoma with humoral hypercalcemia of malignancy (HHM) are presented. RESULTS:The two patients had severe hypercalcemia with...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Lortholary AH,Cadeau SD,Bertrand GM,Guerin-Meyer VI,Gamelin EC,Audran MJ

    更新日期:1999-12-01 00:00:00

  • The epidemiology of renal cell carcinoma. A second look.

    abstract:BACKGROUND:From 1973 to 1991, the incidence of kidney cancer in the United States increased by 35.4%. METHODS:A multicenter, hospital-based case-control study was conducted from 1977 to 1993 through an interview of 788 patients with renal cell carcinoma and 779 control subjects. RESULTS:Compared with those who never ...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/1097-0142(19950515)75:10<2552::aid-cncr282

    authors: Muscat JE,Hoffmann D,Wynder EL

    更新日期:1995-05-15 00:00:00

  • Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy. A Pediatric Oncology Group study.

    abstract::Experience with high-dose cytosine arabinoside (HDAC) in pediatric solid tumors is limited. Sixteen children with solid tumors resistant to conventional therapies were registered in a pilot Pediatric Oncology Group (POG) study that required the administration of HDAC at 3 g/m2 every 12 hours for four doses. There were...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19901115)66:10<2064::aid-cncr282

    authors: Tebbi CK,Krischer J,Fernbach DJ,Mahoney DH,Alvarado C,Camitta B

    更新日期:1990-11-15 00:00:00

  • Halothane, surgery, immunosuppression and artificial pulmonary metastases.

    abstract::C57B1/6 mice were given intravenous tumor cells on day O. Mice were then given either a brief exposure to halothane anesthesia or given halothane and then underwent a hind limb amputation. Immune testing was done at varying time intervals and correlated with the development of artificial pulmonary metastases. The effe...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197803)41:3<827::aid-cncr2820410

    authors: Lundy J,Lovett EJ 3rd,Hamilton S,Conran P

    更新日期:1978-03-01 00:00:00

  • Combination chemotherapy plus levamisole in the treatment of disseminated malignant melanoma. A Southwest Oncology Group study.

    abstract::Two hundred-eighty patients were randomized to receive either BCNU, hydroxyurea and imidazole carboxamide (BHD), BHD plus levamisole, or high-dose DTIC plus actinomycin D. There was no difference in response rate in the three groups (24%, 25% and 22%). Females responded better than males and, as expected, those with a...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19840215)53:4<833::aid-cncr28205

    authors: Costanzi JJ,Fletcher WS,Balcerzak SP,Taylor S,Eyre HJ,O'Bryan RM,Al-Sarraf M,Frank J

    更新日期:1984-02-15 00:00:00

  • Paraneoplastic Cushing's syndrome as an adverse prognostic factor in patients who die early with small cell lung cancer.

    abstract::The potential role of paraneoplastic Cushing's syndrome (CS) was assessed on the clinical course of patients with small cell lung cancer. A retrospective comparison was done of complications and survival rates according to the presence or absence of CS in patients with small cell lung cancer who died within 90 days of...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920101)69:1<66::aid-cncr282069

    authors: Dimopoulos MA,Fernandez JF,Samaan NA,Holoye PY,Vassilopoulou-Sellin R

    更新日期:1992-01-01 00:00:00

  • Dose-escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF-mutated advanced cancers.

    abstract:BACKGROUND:BRAF inhibitors are effective in melanoma and other cancers with BRAF mutations; however, patients ultimately develop therapeutic resistance through the activation of alternative signaling pathways such as RAF/RAS or MET. The authors hypothesized that combining the BRAF inhibitor vemurafenib with either the ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33242

    authors: Janku F,Sakamuri D,Kato S,Huang HJ,Call SG,Naing A,Holley VR,Patel SP,Amaria RN,Falchook GS,Piha-Paul SA,Zinner RG,Tsimberidou AM,Hong DS,Meric-Bernstam F

    更新日期:2021-02-01 00:00:00

  • Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40.

    abstract:BACKGROUND:Non-Hodgkin lymphoma (NHL), the most common cancer of the lymphatic system, is of unknown etiology. The identification of etiologic factors in the onset of NHL is a key event that could facilitate the prevention and cure of this malignancy. Simian virus 40 (SV40) has been considered an oncogenic agent in the...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29404

    authors: Tognon M,Luppi M,Corallini A,Taronna A,Barozzi P,Rotondo JC,Comar M,Casali MV,Bovenzi M,D'Agostino A,Vinante F,Rigo A,Ferrarini I,Barbanti-Brodano G,Martini F,Mazzoni E

    更新日期:2015-08-01 00:00:00

  • Total body irradiation with 8 MeV X-rays in generalized malignant disease.

    abstract::The authors describe their experience with total body irradiation (TBI) with 8 MeV-x rays in the treatment of disseminated tumors. With a dose of 125 rad, given three times with 2-week intervals, some objective remissions (6/26) were obtained, especially in patients with lymphomas. For solid tumors only subjective imp...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197704)39:4<1435::aid-cncr282039

    authors: Huys JV,Simons MJ,Dewulf LM,Schelstraete KH

    更新日期:1977-04-01 00:00:00

  • A prospective trial of recombinant human interferon alpha 2B in previously untreated patients with hepatocellular carcinoma. The Gastrointestinal Tumor Study Group.

    abstract::The Gastrointestinal Tumor Study Group performed a two-stage trial of alpha-2B interferon in 30 hepatocellular carcinoma patients. Two patients did not receive the treatment and are not considered in the analysis. Only two (7%) short-lived objective responses were observed and the median survival time was 22 weeks. To...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19900701)66:1<135::aid-cncr28206

    authors:

    更新日期:1990-07-01 00:00:00